WMT-TCP BONE GRAFT SUBSTITUTE— 510(k) K022629

Name: FDA 510(k) clearance K022629
Creator: U.S. Food and Drug Administration
Published: 2002-11-05

Substantially Equivalent

Wrightmedicaltechnologyinc

FDA 510(k) clearance K022629 for WMT-TCP BONE GRAFT SUBSTITUTE, Substantially Equivalent on 2002-11-05. Applicant: Wrightmedicaltechnologyinc. Device class: 2.

Clearance details

Applicant: Wrightmedicaltechnologyinc
Product code: Code MQV
Device class: Class 2
Regulation: 21 CFR 888.3045
Advisory panel: Orthopedic
Date received: 2002-08-07
Decision date: 2002-11-05
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Arlington, TN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MQV

view all

K262230 — Mg OSTEOREVIVE; Mg OSTEOCRETE2026-09-11
K260364 — Device 300419 Strip2026-06-02
K252797 — JAZBI Resorbable Bone Void Filler2026-05-26
K261008 — Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip +7 more2026-04-24
K253524 — Adaptos®Fuse Bone Graft2026-02-17

More clearances from Wrightmedicaltechnologyinc

view all

K222835 — Prophecy Preoperative Navigation Alignment System2023-01-27
K213342 — PRO-DENSE LoVisc Bone Graft Substitute2022-01-05
K212996 — Sterile PHALINX Hammertoe System2021-11-16
K202815 — PROPHECY Preoperative Navigation Alignment System2021-03-10
K201259 — ORTHOLOC 2 with 3Di Technology Pilon Fracture Plating System2021-01-08

Adverse events under product code MQV

product code MQV

Death: 6
Injury: 435
Total: 441

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.